Cargando…
Penfluridol as a Candidate of Drug Repurposing for Anticancer Agent
Penfluridol has robust antipsychotic efficacy and is a first-generation diphenylbutylpiperidine. Its effects last for several days after a single oral dose and it can be administered once a week to provide better compliance and symptom control. Recently; strong antitumour effects for penfluridol wer...
Autores principales: | Tuan, Nguyen Minh, Lee, Chang Hoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6832311/ https://www.ncbi.nlm.nih.gov/pubmed/31614431 http://dx.doi.org/10.3390/molecules24203659 |
Ejemplares similares
-
Ethacrynic Acid: A Promising Candidate for Drug Repurposing as an Anticancer Agent
por: Yu, Lu, et al.
Publicado: (2023) -
Repurposing Penfluridol in Combination with Temozolomide for the Treatment of Glioblastoma
por: Kim, Hyungsin, et al.
Publicado: (2019) -
Drug repurposing: Antimicrobial and antibiofilm effects of penfluridol against Enterococcus faecalis
por: Zeng, Xianghai, et al.
Publicado: (2020) -
Synergistic Tumor Inhibition via Energy Elimination by Repurposing Penfluridol and 2-Deoxy-D-Glucose in Lung Cancer
por: Lai, Tsung-Ching, et al.
Publicado: (2022) -
Drug repurposing against COVID-19: focus on anticancer agents
por: Ciliberto, Gennaro, et al.
Publicado: (2020)